They have a reason, their new venture (Nuerocyte/Migranade). As I said in the past, they just need to update the holders on progress and direction. This isn't a new product, it's been manufactured in bulk and previously marketed (Hell, it's even appeared on Amazon). They should have some projection numbers based on the scale of past distribution and sales. What those figures may be, I have no idea, but its better than nothing. IMO, there is no reason for this to be sitting idle at this point. GLTA
News 
Market Data 
Discover 
